SEMA7A and experimental autoimmune encephalomyelitis: What is more, SEMA7A is reported to be involved in central nervous system inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis, and SEMA7A can also activate mitogen‐activated protein kinase (MAPK) signaling cascade pathways to affect the formation of neuronal networks in neuronal cells.13, 14